P53 levels in the evaluation of malignant/benign pancreaticobiliary disease: hope or hype?
Gessner
C E
CE
Division of Gastroenterology, Duke University, Durham, NC, USA.
Baillie
J
J
D000906:Antibodies / Q000097:blood; D001661:Biliary Tract Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014408:Biomarkers, Tumor; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D012680:Sensitivity and Specificity; D016159:Tumor Suppressor Protein p53 / Q000097:blood* / Q000276:immunology
D000906:Antibodies; D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53